Clostridium difficile infection: Difference between revisions
Line 25: | Line 25: | ||
* [[Mupirocin]] | * [[Mupirocin]] | ||
* [[Rifabutin]] | * [[Rifabutin]] | ||
* [[Nitrofurantoin]] | |||
==[[Clostridium difficile differential diagnosis|Differentiating Clostridium difficile from other Diseases]]== | ==[[Clostridium difficile differential diagnosis|Differentiating Clostridium difficile from other Diseases]]== |
Revision as of 16:01, 24 October 2014
Resident Survival Guide |
C. difficile Infection Microchapters |
Differentiating Clostridium difficile infectionfrom other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Clostridium difficile infection On the Web |
American Roentgen Ray Society Images of Clostridium difficile infection |
Risk calculators and risk factors for Clostridium difficile infection |
For patient information, click here.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abhishek Deshpande, M.D., Ph.D.
Synonyms and keywords: CDI
Overview
Historical Perspective
Pathophysiology
Causes
Drug Side Effect
Differentiating Clostridium difficile from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Abdominal X Ray | CT | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies